Medicine guide
Rhapsido
As listed in the register: Rhapsido, Filmtabletten
·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Remibrutinibum
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Als Zusatztherapie für die Behandlung einer chronischen spontanen Urtikaria (CSU) bei erwachsenen Patienten, die trotz einer H1-Antihistaminbehandlung symptomatisch bleiben
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Remibrutinibum |
| Used in | Cancer treatments and immune-system medicines |
| Classification | L04AA60 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Rhapsido, Filmtabletten |
| Packs | 60 Tablette(n) |
| Zulassungsnummer | 70227 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.